Cell line with endogenous EGFRvIII expression is a suitable model for research and drug development purposesWojciech J. Stec(Amicus Therapeutics (United Kingdom)), Piotr Rieske(Medical University of Lodz)OncotargetMarch 19, 201610.18632/oncotarget.8201Cited by 27SaveCiteExport RISWatch citationsRelated PapersEGFR Activation Leads to Cell Death Independent of PI3K/AKT/mTOR in an AD293 Cell Line|PLoS ONE|2016|40